Innovative New e-Prescribing Plug-In — BSURE — Delivers Patient-Specific Drug Price Transparency to e-Prescribing Physicians

Austin, TX -- (ReleaseWire) -- 09/30/2015 -- Today WENO Exchange LLC and NewCorp Inc. announced the launch of the new drug price transparency program, called BSURE, across the NewCrop eRx Network. BSURE will give 20,000 e-Prescribers early access to drug prices at the point of care — before they decide & send the prescription to the pharmacy. The BSURE plug in works independently on the physician's electronic health record (EHR) and delivers the drug price by super coordinating all of a patient's known drug benefits such as those from a health plan, a pharmaceutical coupon, and WENO's BSURE cash discount card.

BSURE is the perfect cure for a chronic healthcare problem — prescription abandonment due to sticker shock at the pharmacy counter. Last year, the rate at which new prescriptions were submitted to pharmacies but never picked up by customers — the abandonment rate — reached 6.3 percent, a stunning 24 percent increase over 2008, when the rate was 5.1 percent, according to Wolters Kluwer Pharma Solutions, a market research company that conducted the survey.

"Drug abandonment triggers a chain reaction of problems for patients, physicians, pharmacies, pharmaceutical brands, generics, and insurance companies," said Tina Goodman, CEO of WENO Exchange and inventor of BSURE. "When patients do not get the drugs they need to treat their problem, it leaves them at risk for worsened health, hospitalization, & even death. For physicians, this means dealing with disgruntled patients and increased administrative costs. Pharmacies bare the cost & frustration of filling and restocking the medication. Drug companies lose the same while insurance companies take on more risk. Drug price transparency, at the e-Prescriber's point of care, is the major key to reducing prescription abandonment caused by pharmacy sticker shock. It is no surprise to me that every single physician I've shown BSURE to agrees with me and emphasizes the need is great! I'm glad NewCrop was listening!"

NewCrop eRx network is deploying BSURE in stages. Currently their e-Prescribers see the drug's average cash discount price when the BSURE cash discount card is referred.

With drug price information at their fingertips, physicians will be able to discuss the drug's efficacy and costs with patients in their offices, thereby, mitigating the negative sticker-shock experience. If the patient is not willing to pay the price for the drugs recommended, doctors can recommend therapeutic alternatives.

WENO Exchange is in the process of qualifying up to 50 pharmaceutical brands to have their coupon benefits coordinated with BSURE on the NewCrop eRx Network. The early brand drugs selected by WENO for early adoption of BSURE will have unique e-Prescribing point of care data and benefit coordination not previously available to their industry. It plans to launch BSURE to a wider audience of physicians, health plans and pharmaceutical brands in 2016.

About NewCrop
NewCrop is the leading electronic prescribing service and has been deployed in a wide range of EHRs and medical networks since 2003. The company's user interface allows for rapid installation of fully expedited e-Prescription networking, as well as Meaningful Use certifications, lab integration, secure messaging, registry reporting, DEA-compliant EPCS audit, and more. All services are available as an integrated user interface and/or data services for all individual features, facilitating easy and flexible installations to fast track network and Meaningful Use 2014 certifications. For more information contact Randy Barnes at rbarnes@newcroprx.com or call 541.408.1275.

About WENO Exchange LLC
Weno Exchange LLC (WENO) is an ePrescribing (eRX) network based in Austin, Texas that specializes in drug price transparency through advanced drug benefit coordination. When established in 2011, WENO was hailed as an innovative competitor in an otherwise dominated ePrescribing network market. For more information, go to http://www.wenoexchange.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

E-Prescriptions flow from NewCrop prescribers to previously unconnected pharmacies via the Weno Exchange new e-Prescribing switch

Austin, TX -- (SBWIRE) -- 05/21/2013 -- Weno Exchange LLC ("WEX"), a new e-Prescribing switch, announced today the company is routing e-Prescriptions from NewCrop's large US prescriber base to pharmacies who have never before participated in e-Prescribing. Weno Exchange enters a heavily dominated e-Prescribing switch market with patent pending methods to deliver e-Prescriptions to virtually any US pharmacy, including those desiring to accept e-Prescriptions from prescribers but formerly frustrated by high costs or cumbersome connectivity methods. The new switch has proven to be a game changer in the market by dissolving previous prescriber and pharmacy dependencies on the other dominant e-Prescribing network. More specifically the new switch uniquely offers pharmacies the option to simply sign up for their stand-alone connection to begin receiving e-Prescriptions for only 12 cents per transaction. Pharmacies can also use a software system which has been certified on the new switch.

NewCrop, recognized as an industry leader in e-Prescribing services, has been deployed in a wide range of Electronic Health Records (EHRs) and medical networks since 2003. Weno Exchange, established in 2011, boldly entered the e-Prescribing network market and quickly went to work wooing trading partners with first-to-market strategies that offered both cost savings and easy connectivity methods. The strategy is evidently working well, judging by the company's success in attracting large prescriber services like NewCrop, as well as new pharmacy partners, to their new network service

The role of e-Prescribing switches like Weno Exchange is to provide connectivity so each party's system does not have to individually contract with a multitude of other individual systems in order to e-Prescribe, which would be highly unmanageable, costly, and ineffective.

"It's thrilling to have such an established organization such as NewCrop as trading partners, and it's exciting when pharmacies get that aha moment when they realize they can drop their transaction fees without changing workflows. " states Tina Goodman, CEO of Weno Exchange.

"NewCrop is pleased to be working with Weno Exchange. We look forward to expanding the benefits of true electronic prescribing, connecting doctors to pharmacies we previously could only reach by fax," said Lawrence Susnow, M.D., Co-founder and Chief Medical Officer at NewCrop.

About NewCrop
NewCrop is an industry leading electronic prescribing service that has been deployed in a wide range of EHRs and medical networks since 2003. The company's user interface allows for rapid installation, fully expedited e-Prescription network and Meaningful Use certifications, and EPCS DEA audit. Data services are available for all individual features, facilitating easy and flexible installations to fast track network and Meaningful Use certifications. NewCrop supported 100+ EHR's for 2011 Meaningful Use certification with comprehensive electronic prescribing services. To meet the needs of MU2014, NewCrop is adding a wide range of connectivity and communication modules. For more information, go to http://www.newcroprx.com.

About Weno Exchange LLC (WEX)
Weno Exchange LLC (WEX) is an e-Prescribing network based in Austin, Texas that specializes in routing electronic prescription (eRx) between trading partners. When established in 2011, WEX was hailed as an innovative competitor in an otherwise dominated e-prescribing network market. WEX utilizes its new patent-pending method, which provides the first and only service enabling electronic prescriptions to be sent to any pharmacy nationwide, regardless of participation in an e-prescribing network. In addition, WEX offers health IT trading partners a simplified process toward eRx connectivity. WEX also boasts the industry's highest EHR incentive revenues and pharmacy's lowest transaction fees. WEX's Screen Assurance program provides data sharing assurance and reporting never before available to health plans and drug manufacturers. For more information, go to http://www.wenoexchange.com

Media Contacts:
NewCrop
Randy Barnes, Vice President, Business Development
rbarnes@newcroprx.com
541.318.1027

Weno Exchange LLC
Kevin Pauley, Executive Assistant
kevin@wenoexchange.com
512-366-2027

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

New patent-pending routing method disrupts currently monopolized eRX industry

Austin, TX -- (ReleaseWire) -- 12/19/2012 -- Weno Exchange LLC, a new e-Prescribing (eRX) network switch, announced today it is implementing its patent-pending method of routing electronic prescriptions to now route eRX instantly to all U.S. pharmacies, including pharmacies that do not yet use a certified pharmacy system vendor on its new network switch. The technology disrupts a currently monopolized e-Prescribing industry by breaking the switch dependency barrier previously required for participation in e-Prescribing. It also meets the needs of pharmacies that could not afford to participate in e-Prescribing – but also could not afford losing the additional revenues generated by electronic prescriptions. In doing so, Weno Exchange becomes the first and only switch that enables an EHRs' prescriber base to e-Prescribe to any pharmacy nationwide, which allows them to easily satisfy government standards and meaningful use rules for e-Prescribing.

Weno Exchange provides two methods by which pharmacies can connect to their registered prescribers for the express purposes of e-Prescribing; the Instant Weno Mail Connectivity Method and the Software Direct Connectivity Method. Both methods have the lowest prices in the industry and billing options that include a low monthly flat fee option or the ability to pay only for filled scripts.

The Instant Weno Mail Connectivity Method is software independent and only requires a simple registration so prescribers can see the pharmacy stores' participation in the Weno Exchange database. It delivers prescriptions in both an electronic and fax format, so that if for any reason the pharmacy is unable to connect to Weno Mail, patients are still served in a timely manner. The Software Direct Connectivity Method requires pharmacy software systems to go through a simplified certification process, and routes e-Prescription messages directly to and from the pharmacy's software service.

According to a report issued by the Office of the National Coordinator (ONC Data Brief Number 4, November 2012) e-Prescriptions have increased tenfold since 2008. This has led to a corresponding increase in related e-Prescribing costs to pharmacies, especially independent stores or smaller chains that do not have the luxury of bargaining for volume discounts.

Pharmacies faced with climbing e-Prescribing costs are beginning to shift network loyalties, forcing EHRs to consider certifying with multiple eRx networks in order to increase opportunities for their prescribers to reach their meaningful use eRX measures. With additional meaningful use measures by the federal government set to go into effect in 2014, EHRs scrambling to find options for their prescribers will discover certifying with Weno Exchange provides a fast and easy process while ensuring that all prescriptions routed will qualify for the meaningful use measure.

"Our innovative, patent-pending method of eRX routing bridges the gap between prescribers and pharmacies, where virtually every prescription can be an eRX, and any pharmacy can fill it. Everyone in this industry knows who the dominant e-Prescribing switch is, and without our patent-pending method of eRX delivery, our competing network would not be able to be independent of this dominant switch – which consequently allows us to provide better service at lower cost, and raise the bar on innovation and client satisfaction," stated Tina Goodman, CEO of Weno Exchange LLC.

"I say let freedom ring and let competition do its thing," Goodman continued. "Monopolies can't endure in the American free enterprise system. Little Davids take on mega-corporation monopoly Goliaths everyday in this country -- and win with innovation and superior products and service. It's time somebody stood up to the bully in this industry, so we've loaded our slingshot -- with a better service, an easier participation process, and lower costs -- and taken aim. Who's with us?"

About Weno Exchange LLC (WEX)
Weno Exchange LLC (WEX) is an e-Prescribing network based in Austin, Texas that specializes in routing electronic prescription (eRX) and care coordination standardized messages between trading partners. When established in 2011, WEX was hailed as an innovative competitor in an otherwise dominated e-prescribing network market. WEX utilizes its new patent-pending method, which provides the first and only service enabling electronic prescriptions to be sent to any pharmacy nationwide, regardless of participation in an e-prescribing network. In addition, WEX offers health IT trading partners a simplified process toward eRX certification. WEX also boasts the industry's highest EHR incentive revenues and pharmacy systems' lowest transaction fees. WEX's Screen Assurance program provides data sharing assurance and reporting never before available to health plans and drug manufacturers. For more information, go to www.wenoexchange.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm